1. Home
  2. PEB vs NVCR Comparison

PEB vs NVCR Comparison

Compare PEB & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pebblebrook Hotel Trust of Beneficial Interest

PEB

Pebblebrook Hotel Trust of Beneficial Interest

HOLD

Current Price

$18.33

Market Cap

2.1B

Sector

Real Estate

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$17.94

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEB
NVCR
Founded
2009
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
PEB
NVCR
Price
$18.33
$17.94
Analyst Decision
Hold
Buy
Analyst Count
11
6
Target Price
$13.30
$28.08
AVG Volume (30 Days)
1.9M
1.2M
Earning Date
04-28-2026
04-30-2026
Dividend Yield
0.28%
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
$1,475,544,000.00
$655,353,000.00
Revenue This Year
N/A
$7.72
Revenue Next Year
$2.25
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
1.53
8.28
52 Week Low
$9.99
$9.82
52 Week High
$19.93
$21.45

Technical Indicators

Market Signals
Indicator
PEB
NVCR
Relative Strength Index (RSI) 48.72 57.62
Support Level $18.35 $14.84
Resistance Level $19.73 $18.41
Average True Range (ATR) 0.48 0.77
MACD -0.00 0.07
Stochastic Oscillator 69.78 78.63

Price Performance

Historical Comparison
PEB
NVCR

About PEB Pebblebrook Hotel Trust of Beneficial Interest

Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,052 rooms across 44 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: